Delivery Order SPE2DR25D2014-SPE2DR26FA0H0
- Not listed
- The Defense Logistics Agency awarded a $14.8K delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This competitive, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Monovisc 88 mg/4 ml syringes with a ceiling value of $1,857.18. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $4.17K. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and is scheduled for completion by May 28, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.34 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $12,223.51 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this pharmaceutical distributor. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.59 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,503.52 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 mg/4 mL syringes on December 17, 2025, with completion scheduled for December 18, 2025. This competitive award utilizes a firm fixed-price contract structure with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,938.04 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes. This firm fixed price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a medical supply procurement under a competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,563.34 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 10, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0H0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,233.00 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes. This competitive award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this strategic contract vehicle, AmerisourceBergen provides medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/18/25 |